These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 16251457
21. Physical and transcript map of the hereditary prostate cancer region at xq27. Stephan DA, Howell GR, Teslovich TM, Coffey AJ, Smith L, Bailey-Wilson JE, Malechek L, Gildea D, Smith JR, Gillanders EM, Schleutker J, Hu P, Steingruber HE, Dhami P, Robbins CM, Makalowska I, Carpten JD, Sood R, Mumm S, Reinbold R, Bonner TI, Baffoe-Bonnie A, Bubendorf L, Heiskanen M, Kallioneimi OP, Baxevanis AD, Joseph SS, Zucchi I, Burk RD, Isaacs W, Ross MT, Trent JM. Genomics; 2002 Jan; 79(1):41-50. PubMed ID: 11827456 [Abstract] [Full Text] [Related]
22. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. Cancel-Tassin G, Latil A, Valéri A, Mangin P, Fournier G, Berthon P, Cussenot O. Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747 [Abstract] [Full Text] [Related]
23. Genomic organization, incidence, and localization of the SPAN-x family of cancer-testis antigens in melanoma tumors and cell lines. Westbrook VA, Schoppee PD, Diekman AB, Klotz KL, Allietta M, Hogan KT, Slingluff CL, Patterson JW, Frierson HF, Irvin WP, Flickinger CJ, Coppola MA, Herr JC. Clin Cancer Res; 2004 Jan 01; 10(1 Pt 1):101-12. PubMed ID: 14734458 [Abstract] [Full Text] [Related]
24. The multifunctional role of SPANX-A/D protein subfamily in the promotion of pro-tumoural processes in human melanoma. Urizar-Arenaza I, Benedicto A, Perez-Valle A, Osinalde N, Akimov V, Muñoa-Hoyos I, Rodriguez JA, Asumendi A, Boyano MD, Blagoev B, Kratchmarova I, Subiran N. Sci Rep; 2021 Feb 11; 11(1):3583. PubMed ID: 33574425 [Abstract] [Full Text] [Related]
25. The complex genetic epidemiology of prostate cancer. Schaid DJ. Hum Mol Genet; 2004 Apr 01; 13 Spec No 1():R103-21. PubMed ID: 14749351 [Abstract] [Full Text] [Related]
26. Evidence for a prostate cancer susceptibility locus on the X chromosome. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M, Thibodeau S, Grönberg H, Emanuelsson M, Damber JE, Bergh A, Jonsson BA, Smith J, Bailey-Wilson J, Carpten J, Stephan D, Gillanders E, Amundson I, Kainu T, Freas-Lutz D, Baffoe-Bonnie A, Van Aucken A, Sood R, Collins F, Brownstein M, Trent J. Nat Genet; 1998 Oct 01; 20(2):175-9. PubMed ID: 9771711 [Abstract] [Full Text] [Related]
27. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer. Bergthorsson JT, Johannesdottir G, Arason A, Benediktsdottir KR, Agnarsson BA, Bailey-Wilson JE, Gillanders E, Smith J, Trent J, Barkardottir RB. Hum Genet; 2000 Oct 01; 107(4):372-5. PubMed ID: 11129338 [Abstract] [Full Text] [Related]
28. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q. White KA, Lange EM, Ray AM, Wojno KJ, Cooney KA. Prostate Cancer Prostatic Dis; 2006 Oct 01; 9(3):298-302. PubMed ID: 16733518 [Abstract] [Full Text] [Related]
29. Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. Stanford JL, McDonnell SK, Friedrichsen DM, Carlson EE, Kolb S, Deutsch K, Janer M, Hood L, Ostrander EA, Schaid DJ. Prostate; 2006 Feb 15; 66(3):317-25. PubMed ID: 16245279 [Abstract] [Full Text] [Related]
30. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Albers P, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Guilford P, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L, Stoll H, Weber W, Forman D, Oliver T, Einhorn L, McMaster M, Kramer J, Greene MH, Weber BL, Nathanson KL, Cortessis V, Easton DF, Bishop DT, Stratton MR, Rapley EA. Hum Mol Genet; 2006 Feb 01; 15(3):443-51. PubMed ID: 16407372 [Abstract] [Full Text] [Related]
31. Cloning of mouse Dab2ip gene, a novel member of the RasGTPase-activating protein family and characterization of its regulatory region in prostate. Chen H, Karam JA, Schultz R, Zhang Z, Duncan C, Hsieh JT. DNA Cell Biol; 2006 Apr 01; 25(4):232-45. PubMed ID: 16629596 [Abstract] [Full Text] [Related]
32. A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer. Yaspan BL, McReynolds KM, Elmore JB, Breyer JP, Bradley KM, Smith JR. Hum Genet; 2008 May 01; 123(4):379-86. PubMed ID: 18350320 [Abstract] [Full Text] [Related]
38. X-linked hypoparathyroidism region on Xq27 is evolutionarily conserved with regions on 3q26 and 13q34 and contains a novel P-type ATPase. Andrew Nesbit M, Bowl MR, Harding B, Schlessinger D, Whyte MP, Thakker RV. Genomics; 2004 Dec 01; 84(6):1060-70. PubMed ID: 15533723 [Abstract] [Full Text] [Related]
39. Expression mapping at 12p12-13 in advanced prostate carcinoma. Kibel AS, Huagen J, Guo C, Isaacs WB, Yan Y, Pienta KJ, Goodfellow PJ. Int J Cancer; 2004 May 01; 109(5):668-72. PubMed ID: 14999772 [Abstract] [Full Text] [Related]
40. Involvement of the RNAse L gene in prostate cancer. Kieffer N, Schmitz M, Scheiden R, Nathan M, Faber JC. Bull Soc Sci Med Grand Duche Luxemb; 2006 May 01; (1):21-8. PubMed ID: 16869093 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]